2-tert-butyl-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine;2-tert-butyl-1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazine;(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)-methylazanide;N-tert-butyl-N,1-dimethylpyrrolidin-3-amine;1-tert-butyl-5-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[3,4-b]pyrrole;5-tert-butyl-1-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;5-tert-butyl-2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;2-tert-butyl-4-methyl-1,3,3a,4,5,6,7,7a-octahydroisoindole;1-tert-butyl-4-methylpiperazine;(1-tert-butylpiperidin-3-yl)-methylazanide;1-(1-tert-butylpyrrolidin-2-yl)-N,N-dimethylmethanamine;(1-tert-butylpyrrolidin-3-yl)methyl-methylazanide;N'-tert-butyl-N,N,N'-trimethylethane-1,2-diamine;N,2-dimethyl-N-[(1-methylazetidin-3-yl)methyl]propan-2-amine;ethane;methane;methyl-[(1-propan-2-ylazetidin-3-yl)methyl]azanide;1-methyl-4-propan-2-yl-1,4-diazepane;tetrakis(rubidium(1+))

C176H387N31Rb4 — CID 161237235

IUPAC2-tert-butyl-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine;2-tert-butyl-1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazine;(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)-methylazanide;N-tert-butyl-N,1-dimethylpyrrolidin-3-amine;1-tert-butyl-5-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[3,4-b]pyrrole;5-tert-butyl-1-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;5-tert-butyl-2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;2-tert-butyl-4-methyl-1,3,3a,4,5,6,7,7a-octahydroisoindole;1-tert-butyl-4-methylpiperazine;(1-tert-butylpiperidin-3-yl)-methylazanide;1-(1-tert-butylpyrrolidin-2-yl)-N,N-dimethylmethanamine;(1-tert-butylpyrrolidin-3-yl)methyl-methylazanide;N'-tert-butyl-N,N,N'-trimethylethane-1,2-diamine;N,2-dimethyl-N-[(1-methylazetidin-3-yl)methyl]propan-2-amine;ethane;methane;methyl-[(1-propan-2-ylazetidin-3-yl)methyl]azanide;1-methyl-4-propan-2-yl-1,4-diazepane;tetrakis(rubidium(1+))
SMILESC.C.C.C.C.C.C.C.C.CC.CC(C)(C)N1CCN2CCCC2C1.CC(C)(C)N1CCN2CCCCC2C1.CC(C)N1CCCN(C)CC1.CC1CCCC2CN(C(C)(C)C)CC12.CN(C)CC1CCCN1C(C)(C)C.CN(C)CCN(C)C(C)(C)C.CN1CC(CN(C)C(C)(C)C)C1.CN1CC2CCN(C(C)(C)C)C2C1.CN1CC2CN(C(C)(C)C)CC2C1.CN1CCC(N(C)C(C)(C)C)C1.CN1CCC2CN(C(C)(C)C)CC21.CN1CCN(C(C)(C)C)CC1.C[N-]C1C2CN(C(C)(C)C)CC21.C[N-]C1CCCN(C(C)(C)C)C1.C[N-]CC1CCN(C(C)(C)C)C1.C[N-]CC1CN(C(C)C)C1.[Rb+].[Rb+].[Rb+].[Rb+]
InChIInChI=1S/C13H25N.C12H24N2.4C11H22N2.C11H24N2.C10H19N2.2C10H22N2.2C10H21N2.2C9H20N2.C9H22N2.C8H17N2.C2H6.9CH4.4Rb/c1-10-6-5-7-11-8-14(9-12(10)11)13(2,3)4;1-12(2,3)14-9-8-13-7-5-4-6-11(13)10-14;1-11(2,3)13-7-9-5-12(4)6-10(9)8-13;1-11(2,3)13-6-5-9-7-12(4)8-10(9)13;1-11(2,3)13-7-9-5-6-12(4)10(9)8-13;1-11(2,3)13-8-7-12-6-4-5-10(12)9-13;1-11(2,3)13-8-6-7-10(13)9-12(4)5;1-10(2,3)12-5-7-8(6-12)9(7)11-4;1-10(2,3)12(5)8-9-6-11(4)7-9;1-10(2,3)12(5)9-6-7-11(4)8-9;1-10(2,3)12-6-5-9(8-12)7-11-4;1-10(2,3)12-7-5-6-9(8-12)11-4;1-9(2,3)11-7-5-10(4)6-8-11;1-9(2)11-6-4-5-10(3)7-8-11;1-9(2,3)11(6)8-7-10(4)5;1-7(2)10-5-8(6-10)4-9-3;1-2;;;;;;;;;;;;;/h10-12H,5-9H2,1-4H3;11H,4-10H2,1-3H3;3*9-10H,5-8H2,1-4H3;10H,4-9H2,1-3H3;10H,6-9H2,1-5H3;7-9H,5-6H2,1-4H3;2*9H,6-8H2,1-5H3;2*9H,5-8H2,1-4H3;5-8H2,1-4H3;9H,4-8H2,1-3H3;7-8H2,1-6H3;7-8H,4-6H2,1-3H3;1-2H3;9*1H4;;;;/q;;;;;;;-1;;;2*-1;;;;-1;;;;;;;;;;;4*+1
InChIKeyUZNPBEQYHBJMBX-UHFFFAOYSA-N
MW3280.12 g/mol
LogP20.82
Rot. Bonds16

About 2-tert-butyl-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine;2-tert-butyl-1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazine;(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)-methylazanide;N-tert-butyl-N,1-dimethylpyrrolidin-3-amine;1-tert-butyl-5-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[3,4-b]pyrrole;5-tert-butyl-1-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;5-tert-butyl-2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;2-tert-butyl-4-methyl-1,3,3a,4,5,6,7,7a-octahydroisoindole;1-tert-butyl-4-methylpiperazine;(1-tert-butylpiperidin-3-yl)-methylazanide;1-(1-tert-butylpyrrolidin-2-yl)-N,N-dimethylmethanamine;(1-tert-butylpyrrolidin-3-yl)methyl-methylazanide;N'-tert-butyl-N,N,N'-trimethylethane-1,2-diamine;N,2-dimethyl-N-[(1-methylazetidin-3-yl)methyl]propan-2-amine;ethane;methane;methyl-[(1-propan-2-ylazetidin-3-yl)methyl]azanide;1-methyl-4-propan-2-yl-1,4-diazepane;tetrakis(rubidium(1+))

2-tert-butyl-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine;2-tert-butyl-1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazine;(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)-methylazanide;N-tert-butyl-N,1-dimethylpyrrolidin-3-amine;1-tert-butyl-5-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[3,4-b]pyrrole;5-tert-butyl-1-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;5-tert-butyl-2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;2-tert-butyl-4-methyl-1,3,3a,4,5,6,7,7a-octahydroisoindole;1-tert-butyl-4-methylpiperazine;(1-tert-butylpiperidin-3-yl)-methylazanide;1-(1-tert-butylpyrrolidin-2-yl)-N,N-dimethylmethanamine;(1-tert-butylpyrrolidin-3-yl)methyl-methylazanide;N'-tert-butyl-N,N,N'-trimethylethane-1,2-diamine;N,2-dimethyl-N-[(1-methylazetidin-3-yl)methyl]propan-2-amine;ethane;methane;methyl-[(1-propan-2-ylazetidin-3-yl)methyl]azanide;1-methyl-4-propan-2-yl-1,4-diazepane;tetrakis(rubidium(1+)) (PubChem CID 161237235) has the molecular formula C176H387N31Rb4 and a molecular weight of 3280.12 g/mol. Its IUPAC name is 2-tert-butyl-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine;2-tert-butyl-1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazine;(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)-methylazanide;N-tert-butyl-N,1-dimethylpyrrolidin-3-amine;1-tert-butyl-5-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[3,4-b]pyrrole;5-tert-butyl-1-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;5-tert-butyl-2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;2-tert-butyl-4-methyl-1,3,3a,4,5,6,7,7a-octahydroisoindole;1-tert-butyl-4-methylpiperazine;(1-tert-butylpiperidin-3-yl)-methylazanide;1-(1-tert-butylpyrrolidin-2-yl)-N,N-dimethylmethanamine;(1-tert-butylpyrrolidin-3-yl)methyl-methylazanide;N'-tert-butyl-N,N,N'-trimethylethane-1,2-diamine;N,2-dimethyl-N-[(1-methylazetidin-3-yl)methyl]propan-2-amine;ethane;methane;methyl-[(1-propan-2-ylazetidin-3-yl)methyl]azanide;1-methyl-4-propan-2-yl-1,4-diazepane;tetrakis(rubidium(1+)).

Molecular Properties

Compound Name2-tert-butyl-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine;2-tert-butyl-1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazine;(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)-methylazanide;N-tert-butyl-N,1-dimethylpyrrolidin-3-amine;1-tert-butyl-5-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[3,4-b]pyrrole;5-tert-butyl-1-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;5-tert-butyl-2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;2-tert-butyl-4-methyl-1,3,3a,4,5,6,7,7a-octahydroisoindole;1-tert-butyl-4-methylpiperazine;(1-tert-butylpiperidin-3-yl)-methylazanide;1-(1-tert-butylpyrrolidin-2-yl)-N,N-dimethylmethanamine;(1-tert-butylpyrrolidin-3-yl)methyl-methylazanide;N'-tert-butyl-N,N,N'-trimethylethane-1,2-diamine;N,2-dimethyl-N-[(1-methylazetidin-3-yl)methyl]propan-2-amine;ethane;methane;methyl-[(1-propan-2-ylazetidin-3-yl)methyl]azanide;1-methyl-4-propan-2-yl-1,4-diazepane;tetrakis(rubidium(1+))
PubChem CID161237235
Molecular FormulaC176H387N31Rb4
Molecular Weight3280.12 g/mol
Exact Mass3275.77
IUPAC Name2-tert-butyl-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine;2-tert-butyl-1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazine;(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)-methylazanide;N-tert-butyl-N,1-dimethylpyrrolidin-3-amine;1-tert-butyl-5-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[3,4-b]pyrrole;5-tert-butyl-1-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;5-tert-butyl-2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;2-tert-butyl-4-methyl-1,3,3a,4,5,6,7,7a-octahydroisoindole;1-tert-butyl-4-methylpiperazine;(1-tert-butylpiperidin-3-yl)-methylazanide;1-(1-tert-butylpyrrolidin-2-yl)-N,N-dimethylmethanamine;(1-tert-butylpyrrolidin-3-yl)methyl-methylazanide;N'-tert-butyl-N,N,N'-trimethylethane-1,2-diamine;N,2-dimethyl-N-[(1-methylazetidin-3-yl)methyl]propan-2-amine;ethane;methane;methyl-[(1-propan-2-ylazetidin-3-yl)methyl]azanide;1-methyl-4-propan-2-yl-1,4-diazepane;tetrakis(rubidium(1+))
SMILESC.C.C.C.C.C.C.C.C.CC.CC(C)(C)N1CCN2CCCC2C1.CC(C)(C)N1CCN2CCCCC2C1.CC(C)N1CCCN(C)CC1.CC1CCCC2CN(C(C)(C)C)CC12.CN(C)CC1CCCN1C(C)(C)C.CN(C)CCN(C)C(C)(C)C.CN1CC(CN(C)C(C)(C)C)C1.CN1CC2CCN(C(C)(C)C)C2C1.CN1CC2CN(C(C)(C)C)CC2C1.CN1CCC(N(C)C(C)(C)C)C1.CN1CCC2CN(C(C)(C)C)CC21.CN1CCN(C(C)(C)C)CC1.C[N-]C1C2CN(C(C)(C)C)CC21.C[N-]C1CCCN(C(C)(C)C)C1.C[N-]CC1CCN(C(C)(C)C)C1.C[N-]CC1CN(C(C)C)C1.[Rb+].[Rb+].[Rb+].[Rb+]
InChIInChI=1S/C13H25N.C12H24N2.4C11H22N2.C11H24N2.C10H19N2.2C10H22N2.2C10H21N2.2C9H20N2.C9H22N2.C8H17N2.C2H6.9CH4.4Rb/c1-10-6-5-7-11-8-14(9-12(10)11)13(2,3)4;1-12(2,3)14-9-8-13-7-5-4-6-11(13)10-14;1-11(2,3)13-7-9-5-12(4)6-10(9)8-13;1-11(2,3)13-6-5-9-7-12(4)8-10(9)13;1-11(2,3)13-7-9-5-6-12(4)10(9)8-13;1-11(2,3)13-8-7-12-6-4-5-10(12)9-13;1-11(2,3)13-8-6-7-10(13)9-12(4)5;1-10(2,3)12-5-7-8(6-12)9(7)11-4;1-10(2,3)12(5)8-9-6-11(4)7-9;1-10(2,3)12(5)9-6-7-11(4)8-9;1-10(2,3)12-6-5-9(8-12)7-11-4;1-10(2,3)12-7-5-6-9(8-12)11-4;1-9(2,3)11-7-5-10(4)6-8-11;1-9(2)11-6-4-5-10(3)7-8-11;1-9(2,3)11(6)8-7-10(4)5;1-7(2)10-5-8(6-10)4-9-3;1-2;;;;;;;;;;;;;/h10-12H,5-9H2,1-4H3;11H,4-10H2,1-3H3;3*9-10H,5-8H2,1-4H3;10H,4-9H2,1-3H3;10H,6-9H2,1-5H3;7-9H,5-6H2,1-4H3;2*9H,6-8H2,1-5H3;2*9H,5-8H2,1-4H3;5-8H2,1-4H3;9H,4-8H2,1-3H3;7-8H2,1-6H3;7-8H,4-6H2,1-3H3;1-2H3;9*1H4;;;;/q;;;;;;;-1;;;2*-1;;;;-1;;;;;;;;;;;4*+1
InChIKeyUZNPBEQYHBJMBX-UHFFFAOYSA-N
XLogP20.82
TPSA143.88 Ų
H-Bond Donors
H-Bond Acceptors27
Rotatable Bonds16
Heavy Atoms211
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003280.12
LogP ≤ 520.82
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1027

Analyze 2-tert-butyl-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine;2-tert-butyl-1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazine;(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)-methylazanide;N-tert-butyl-N,1-dimethylpyrrolidin-3-amine;1-tert-butyl-5-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[3,4-b]pyrrole;5-tert-butyl-1-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;5-tert-butyl-2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;2-tert-butyl-4-methyl-1,3,3a,4,5,6,7,7a-octahydroisoindole;1-tert-butyl-4-methylpiperazine;(1-tert-butylpiperidin-3-yl)-methylazanide;1-(1-tert-butylpyrrolidin-2-yl)-N,N-dimethylmethanamine;(1-tert-butylpyrrolidin-3-yl)methyl-methylazanide;N'-tert-butyl-N,N,N'-trimethylethane-1,2-diamine;N,2-dimethyl-N-[(1-methylazetidin-3-yl)methyl]propan-2-amine;ethane;methane;methyl-[(1-propan-2-ylazetidin-3-yl)methyl]azanide;1-methyl-4-propan-2-yl-1,4-diazepane;tetrakis(rubidium(1+)) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-tert-butyl-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine;2-tert-butyl-1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazine;(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)-methylazanide;N-tert-butyl-N,1-dimethylpyrrolidin-3-amine;1-tert-butyl-5-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[3,4-b]pyrrole;5-tert-butyl-1-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;5-tert-butyl-2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;2-tert-butyl-4-methyl-1,3,3a,4,5,6,7,7a-octahydroisoindole;1-tert-butyl-4-methylpiperazine;(1-tert-butylpiperidin-3-yl)-methylazanide;1-(1-tert-butylpyrrolidin-2-yl)-N,N-dimethylmethanamine;(1-tert-butylpyrrolidin-3-yl)methyl-methylazanide;N'-tert-butyl-N,N,N'-trimethylethane-1,2-diamine;N,2-dimethyl-N-[(1-methylazetidin-3-yl)methyl]propan-2-amine;ethane;methane;methyl-[(1-propan-2-ylazetidin-3-yl)methyl]azanide;1-methyl-4-propan-2-yl-1,4-diazepane;tetrakis(rubidium(1+))?
The IUPAC name of 2-tert-butyl-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine;2-tert-butyl-1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazine;(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)-methylazanide;N-tert-butyl-N,1-dimethylpyrrolidin-3-amine;1-tert-butyl-5-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[3,4-b]pyrrole;5-tert-butyl-1-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;5-tert-butyl-2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;2-tert-butyl-4-methyl-1,3,3a,4,5,6,7,7a-octahydroisoindole;1-tert-butyl-4-methylpiperazine;(1-tert-butylpiperidin-3-yl)-methylazanide;1-(1-tert-butylpyrrolidin-2-yl)-N,N-dimethylmethanamine;(1-tert-butylpyrrolidin-3-yl)methyl-methylazanide;N'-tert-butyl-N,N,N'-trimethylethane-1,2-diamine;N,2-dimethyl-N-[(1-methylazetidin-3-yl)methyl]propan-2-amine;ethane;methane;methyl-[(1-propan-2-ylazetidin-3-yl)methyl]azanide;1-methyl-4-propan-2-yl-1,4-diazepane;tetrakis(rubidium(1+)) (CID 161237235) is 2-tert-butyl-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine;2-tert-butyl-1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazine;(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)-methylazanide;N-tert-butyl-N,1-dimethylpyrrolidin-3-amine;1-tert-butyl-5-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[3,4-b]pyrrole;5-tert-butyl-1-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;5-tert-butyl-2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;2-tert-butyl-4-methyl-1,3,3a,4,5,6,7,7a-octahydroisoindole;1-tert-butyl-4-methylpiperazine;(1-tert-butylpiperidin-3-yl)-methylazanide;1-(1-tert-butylpyrrolidin-2-yl)-N,N-dimethylmethanamine;(1-tert-butylpyrrolidin-3-yl)methyl-methylazanide;N'-tert-butyl-N,N,N'-trimethylethane-1,2-diamine;N,2-dimethyl-N-[(1-methylazetidin-3-yl)methyl]propan-2-amine;ethane;methane;methyl-[(1-propan-2-ylazetidin-3-yl)methyl]azanide;1-methyl-4-propan-2-yl-1,4-diazepane;tetrakis(rubidium(1+)).
What is the SMILES notation for 2-tert-butyl-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine;2-tert-butyl-1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazine;(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)-methylazanide;N-tert-butyl-N,1-dimethylpyrrolidin-3-amine;1-tert-butyl-5-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[3,4-b]pyrrole;5-tert-butyl-1-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;5-tert-butyl-2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;2-tert-butyl-4-methyl-1,3,3a,4,5,6,7,7a-octahydroisoindole;1-tert-butyl-4-methylpiperazine;(1-tert-butylpiperidin-3-yl)-methylazanide;1-(1-tert-butylpyrrolidin-2-yl)-N,N-dimethylmethanamine;(1-tert-butylpyrrolidin-3-yl)methyl-methylazanide;N'-tert-butyl-N,N,N'-trimethylethane-1,2-diamine;N,2-dimethyl-N-[(1-methylazetidin-3-yl)methyl]propan-2-amine;ethane;methane;methyl-[(1-propan-2-ylazetidin-3-yl)methyl]azanide;1-methyl-4-propan-2-yl-1,4-diazepane;tetrakis(rubidium(1+))?
The canonical SMILES for 2-tert-butyl-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine;2-tert-butyl-1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazine;(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)-methylazanide;N-tert-butyl-N,1-dimethylpyrrolidin-3-amine;1-tert-butyl-5-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[3,4-b]pyrrole;5-tert-butyl-1-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;5-tert-butyl-2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;2-tert-butyl-4-methyl-1,3,3a,4,5,6,7,7a-octahydroisoindole;1-tert-butyl-4-methylpiperazine;(1-tert-butylpiperidin-3-yl)-methylazanide;1-(1-tert-butylpyrrolidin-2-yl)-N,N-dimethylmethanamine;(1-tert-butylpyrrolidin-3-yl)methyl-methylazanide;N'-tert-butyl-N,N,N'-trimethylethane-1,2-diamine;N,2-dimethyl-N-[(1-methylazetidin-3-yl)methyl]propan-2-amine;ethane;methane;methyl-[(1-propan-2-ylazetidin-3-yl)methyl]azanide;1-methyl-4-propan-2-yl-1,4-diazepane;tetrakis(rubidium(1+)) is C.C.C.C.C.C.C.C.C.CC.CC(C)(C)N1CCN2CCCC2C1.CC(C)(C)N1CCN2CCCCC2C1.CC(C)N1CCCN(C)CC1.CC1CCCC2CN(C(C)(C)C)CC12.CN(C)CC1CCCN1C(C)(C)C.CN(C)CCN(C)C(C)(C)C.CN1CC(CN(C)C(C)(C)C)C1.CN1CC2CCN(C(C)(C)C)C2C1.CN1CC2CN(C(C)(C)C)CC2C1.CN1CCC(N(C)C(C)(C)C)C1.CN1CCC2CN(C(C)(C)C)CC21.CN1CCN(C(C)(C)C)CC1.C[N-]C1C2CN(C(C)(C)C)CC21.C[N-]C1CCCN(C(C)(C)C)C1.C[N-]CC1CCN(C(C)(C)C)C1.C[N-]CC1CN(C(C)C)C1.[Rb+].[Rb+].[Rb+].[Rb+].
What is the InChIKey of 2-tert-butyl-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine;2-tert-butyl-1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazine;(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)-methylazanide;N-tert-butyl-N,1-dimethylpyrrolidin-3-amine;1-tert-butyl-5-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[3,4-b]pyrrole;5-tert-butyl-1-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;5-tert-butyl-2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;2-tert-butyl-4-methyl-1,3,3a,4,5,6,7,7a-octahydroisoindole;1-tert-butyl-4-methylpiperazine;(1-tert-butylpiperidin-3-yl)-methylazanide;1-(1-tert-butylpyrrolidin-2-yl)-N,N-dimethylmethanamine;(1-tert-butylpyrrolidin-3-yl)methyl-methylazanide;N'-tert-butyl-N,N,N'-trimethylethane-1,2-diamine;N,2-dimethyl-N-[(1-methylazetidin-3-yl)methyl]propan-2-amine;ethane;methane;methyl-[(1-propan-2-ylazetidin-3-yl)methyl]azanide;1-methyl-4-propan-2-yl-1,4-diazepane;tetrakis(rubidium(1+))?
The InChIKey is UZNPBEQYHBJMBX-UHFFFAOYSA-N. The full InChI is InChI=1S/C13H25N.C12H24N2.4C11H22N2.C11H24N2.C10H19N2.2C10H22N2.2C10H21N2.2C9H20N2.C9H22N2.C8H17N2.C2H6.9CH4.4Rb/c1-10-6-5-7-11-8-14(9-12(10)11)13(2,3)4;1-12(2,3)14-9-8-13-7-5-4-6-11(13)10-14;1-11(2,3)13-7-9-5-12(4)6-10(9)8-13;1-11(2,3)13-6-5-9-7-12(4)8-10(9)13;1-11(2,3)13-7-9-5-6-12(4)10(9)8-13;1-11(2,3)13-8-7-12-6-4-5-10(12)9-13;1-11(2,3)13-8-6-7-10(13)9-12(4)5;1-10(2,3)12-5-7-8(6-12)9(7)11-4;1-10(2,3)12(5)8-9-6-11(4)7-9;1-10(2,3)12(5)9-6-7-11(4)8-9;1-10(2,3)12-6-5-9(8-12)7-11-4;1-10(2,3)12-7-5-6-9(8-12)11-4;1-9(2,3)11-7-5-10(4)6-8-11;1-9(2)11-6-4-5-10(3)7-8-11;1-9(2,3)11(6)8-7-10(4)5;1-7(2)10-5-8(6-10)4-9-3;1-2;;;;;;;;;;;;;/h10-12H,5-9H2,1-4H3;11H,4-10H2,1-3H3;3*9-10H,5-8H2,1-4H3;10H,4-9H2,1-3H3;10H,6-9H2,1-5H3;7-9H,5-6H2,1-4H3;2*9H,6-8H2,1-5H3;2*9H,5-8H2,1-4H3;5-8H2,1-4H3;9H,4-8H2,1-3H3;7-8H2,1-6H3;7-8H,4-6H2,1-3H3;1-2H3;9*1H4;;;;/q;;;;;;;-1;;;2*-1;;;;-1;;;;;;;;;;;4*+1.
What are the key properties of 2-tert-butyl-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine;2-tert-butyl-1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazine;(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)-methylazanide;N-tert-butyl-N,1-dimethylpyrrolidin-3-amine;1-tert-butyl-5-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[3,4-b]pyrrole;5-tert-butyl-1-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;5-tert-butyl-2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;2-tert-butyl-4-methyl-1,3,3a,4,5,6,7,7a-octahydroisoindole;1-tert-butyl-4-methylpiperazine;(1-tert-butylpiperidin-3-yl)-methylazanide;1-(1-tert-butylpyrrolidin-2-yl)-N,N-dimethylmethanamine;(1-tert-butylpyrrolidin-3-yl)methyl-methylazanide;N'-tert-butyl-N,N,N'-trimethylethane-1,2-diamine;N,2-dimethyl-N-[(1-methylazetidin-3-yl)methyl]propan-2-amine;ethane;methane;methyl-[(1-propan-2-ylazetidin-3-yl)methyl]azanide;1-methyl-4-propan-2-yl-1,4-diazepane;tetrakis(rubidium(1+))?
2-tert-butyl-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine;2-tert-butyl-1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazine;(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)-methylazanide;N-tert-butyl-N,1-dimethylpyrrolidin-3-amine;1-tert-butyl-5-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[3,4-b]pyrrole;5-tert-butyl-1-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;5-tert-butyl-2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;2-tert-butyl-4-methyl-1,3,3a,4,5,6,7,7a-octahydroisoindole;1-tert-butyl-4-methylpiperazine;(1-tert-butylpiperidin-3-yl)-methylazanide;1-(1-tert-butylpyrrolidin-2-yl)-N,N-dimethylmethanamine;(1-tert-butylpyrrolidin-3-yl)methyl-methylazanide;N'-tert-butyl-N,N,N'-trimethylethane-1,2-diamine;N,2-dimethyl-N-[(1-methylazetidin-3-yl)methyl]propan-2-amine;ethane;methane;methyl-[(1-propan-2-ylazetidin-3-yl)methyl]azanide;1-methyl-4-propan-2-yl-1,4-diazepane;tetrakis(rubidium(1+)) has a molecular weight of 3280.12 g/mol, XLogP of 20.82, 16 rotatable bonds, 0 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for 2-tert-butyl-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine;2-tert-butyl-1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazine;(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)-methylazanide;N-tert-butyl-N,1-dimethylpyrrolidin-3-amine;1-tert-butyl-5-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[3,4-b]pyrrole;5-tert-butyl-1-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;5-tert-butyl-2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;2-tert-butyl-4-methyl-1,3,3a,4,5,6,7,7a-octahydroisoindole;1-tert-butyl-4-methylpiperazine;(1-tert-butylpiperidin-3-yl)-methylazanide;1-(1-tert-butylpyrrolidin-2-yl)-N,N-dimethylmethanamine;(1-tert-butylpyrrolidin-3-yl)methyl-methylazanide;N'-tert-butyl-N,N,N'-trimethylethane-1,2-diamine;N,2-dimethyl-N-[(1-methylazetidin-3-yl)methyl]propan-2-amine;ethane;methane;methyl-[(1-propan-2-ylazetidin-3-yl)methyl]azanide;1-methyl-4-propan-2-yl-1,4-diazepane;tetrakis(rubidium(1+)) is sourced from PubChem (CID 161237235), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).